Background: Patients with autosomal dominant Sorsby's fundus dystrophy
are at high risk of severe visual loss due to choroidal neovasculariz
ation (CNV) during the fourth or fifth decade of life. Methods: To ass
ess the efficacy of argon laser photocoagulation for extrafoveal well-
defined CNV, we analyzed retrospectively the clinical course in 10 eye
s of 7 patients who had Sorsby's fundus dystrophy with CNV 200 mum to
2,500 mum from the center of the foveal avascular zone, and who subseq
uently underwent laser photocoagulation. Results: All treated eyes dev
eloped severe visual loss as a consequence of recurrent or persistent
CNV occurring on the foveal side of the treatment scar, which extended
under the fovea. The average time until occurrence of angiographicall
y documented CNV after initial treatment was 8.1 +/- 8.9 weeks, but ra
nged from 2 weeks to 32 weeks. Retreatment for persistent or recurrent
extrafoveal CNV was performed in 5 eyes, but CNV recurred in all 5. C
onclusions: Results of this study suggest that the risk of persistence
or recurrence of CNV after laser photocoagulation for extrafoveal CNV
is unusually high in patients with Sorsby's fundus dystrophy, and tha
t this treatment is ineffective in preventing severe visual loss in su
ch patients.